The Maryland biotech firm has been accused of using its links with the Trump administration to land hundreds of millions of dollars in contracts for coronavirus shots.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.